Histone methylation is involved in the regulation of gene expression and DNA replication through alteration of chromatin structure. We earlier showed that SMYD3, a histone H3-lysine 4-specific methyltransferase, is frequently upregulated in human colorectal, liver and breast cancer compared to their matched non-cancerous cells, and that its activity is associated with the growth of these tumors. In the present study, we found that human cancer cells express both the full-length and a cleaved form of SMYD3 protein. Amino acid sequence analysis uncovered that the cleaved form lacks the 34 amino acids in the N-terminal region of the full-length protein. Interestingly, the cleaved protein and mutant protein containing substitutions at glycines 15 and 17, two highly conserved amino acids in the N-terminal region, revealed a higher histone methyltransferase (HMTase) activity compared to the full-length protein. Furthermore, the N-terminal region is responsible for the association with heat shock protein 90a (HSP90a). These data indicate that the N-terminal region plays an important role for the regulation of its methyltransferase activity and suggest that a structural change of the protein through the cleavage of the region or interaction with HSP90a may be involved in the modulation. These findings may help for a better understanding of the mechanisms that modulate the HMTase activity of SMYD3, and contribute to the development of novel anticancer drugs targeting SMYD3 methyltransferase activity.
Histone methylation is involved in the regulation of gene expression and DNA replication through alteration of chromatin structure. We earlier showed that SMYD3, a histone H3-lysine 4-specific methyltransferase, is frequently upregulated in human colorectal, liver and breast cancer compared to their matched non-cancerous cells, and that its activity is associated with the growth of these tumors. In the present study, we found that human cancer cells express both the full-length and a cleaved form of SMYD3 protein. Amino acid sequence analysis uncovered that the cleaved form lacks the 34 amino acids in the N-terminal region of the full-length protein.
Interestingly, the cleaved protein and mutant protein containing substitutions at glycines 15 and 17, two highly conserved amino acids in the N-terminal region, revealed a higher histone methyltransferase (HMTase) activity compared to the full-length protein. Furthermore, the N-terminal region is responsible for the association with heat shock protein 90a (HSP90a). These data indicate that the N-terminal region plays an important role for the regulation of its methyltransferase activity and suggest that a structural change of the protein through the cleavage of the region or interaction with HSP90a may be involved in the modulation. These findings may help for a better understanding of the mechanisms that modulate the HMTase activity of SMYD3, and contribute to theIntroduction Modifications at histone tails play a crucial role in the regulation of transcription, DNA replication, telomere maintenance and cell division. Modifications include methylation, phosphorylation, acetylation and ubiquitination at various residues of histone tails (Peterson and Laniel, 2004) . The combination and degree of the modifications lead to association or dissociation of chromatin-interacting proteins to the histone octamer, and thereby defines chromatin structure. Conformational change of chromatin is a key factor for transcription; untranscribed genes are compacted in heterochromatin, while transcribed genes are in euchromatin, where transcriptional complexes are accessible to the target DNA (Jenuwein and Allis, 2001 ). Methylation of H3 lysine 4 (H3-K4) has been shown to associate with transcriptional activation, while that of H3 lysine 9 or 27 (H3-K9 or H3-K27) with transcriptional repression (Jenuwein and Allis, 2001; Cao et al., 2002; Lachner and Jenuwein, 2002) . Lysine histone methyltransferases (HMTases) have a conserved SET domain that provides a place where methyl donor transfers H-residues to their target substrate(s). The crystal structure of Set1, a histone H3-K4 methyltransferase, demonstrated a dimerization of the SET domain forming a donut-like structure, in which the histone tail associates with the methyl donor (Tresaugues et al., 2006) . Although studies on HMTases have accumulated a link between histone methylation and gene expression, the regulatory mechanism(s) of methyltransferases remains to be elucidated.
Recent molecular studies have disclosed that alterations of global histone modification play a role in human tumorigenesis (Varambally et al., 2002) . We earlier reported that SMYD3, a histone H3-K4-specific methyltransferase, was frequently overexpressed in human colorectal, liver and breast cancers, and that its enhanced expression was essential for the growth of cancer cells (Hamamoto et al., 2004 (Hamamoto et al., , 2006 . SMYD3 encoded a 428-amino acid-protein containing a SET domain (codons 117-246), a zf-MYND domain (codons 49-87) and a SET-N region (codons 5-27) . Mutation in the conserved sequence of the SET domain abolished the interaction of SMYD3 with methyl donor, showing that the SET domain is crucial for its methyltransferase activity. The role of SET-N region has not yet been disclosed. SMYD3 promoted di-and tri-methylation in H3-K4, which was enhanced by the interaction with heat shock protein 90a (HSP90a). We further clarified that SMYD3 interacted with an RNA helicase to form a complex with RNA polymerase II, and that SMYD3 transactivated direct target genes including Nkx2.8 and WNT10B. Further investigations identified E2F1-binding elements in the 5 0 flanking region of SMYD3, and its expression was enhanced by elevated E2F1 that is frequently activated in human cancer by the inactivation of retinoblastoma protein 1 through its phosphorylation by cyclin-dependent kinases or an interaction with viral proteins (Tsuge et al., 2005) .
We here report that cells express both full-length SMYD3 and a cleaved form of the protein that lacks 34 N-terminal amino acids. The cleaved protein and mutant protein containing substitutions in the conserved amino acids in the SET-N region showed enhanced HMTase activities compared to the full-length protein.
Since HSP90a associates with the full-length protein but not with the cleaved or mutant protein, conformational change by the cleavage or the binding with HSP90a may play a role in the regulation of SMYD3 HMTase activity. These findings will help to better understand the regulatory mechanisms of SMYD3 HMTase activity, and contribute to the development of HMTase inhibitors.
Results
A cleaved form of SMYD3 protein in human cancer cells We showed in our earlier studies that the expression levels of SMYD3 protein are elevated in human hepatocellular carcinoma (HCC), colorectal carcinoma (CRC) and breast cancer (Hamamoto et al., 2004 (Hamamoto et al., , 2006 . Interestingly, western blot analysis with anti-SMYD3 antibody showed two bands of 45-and 42-kDa in all breast cancer tissues examined, but it detected neither of the two bands in normal mammary gland. Both the 45-and 42-kDa bands were observed in HCC, CRC and breast cancer cell lines ( Figure 1a ) and normal testis (data not shown). The predicted molecular weight of SMYD3 was 45 kDa, and we did not find any other alternative splicing forms of SMYD3 transcript in our reverse transcriptase (RT)-PCR analysis. Therefore, we hypothesized that the 42-kDa band might result from cleavage of the full-length SMYD3 protein. To examine the cleavage of SMYD3, we prepared plasmids expressing N-terminal HA-tagged SMYD3 or C-terminal FLAG-tagged SMYD3. Extracts of HEK293 cells expressing HA-or FLAG-tagged SMYD3 protein were used for immunoblot analysis with anti-HA or anti-FLAG antibodies, respectively. Although analysis of extract from cells expressing FLAG-tagged SMYD3 showed two bands with anti-FLAG antibody, analysis of cells expressing HA-tagged SMYD3 detected only one band with anti-HA antibody (Figure 1b) . We further expressed N-terminal FLAG-tagged SMYD3 in HEK293 cells that do not express endogenous SMYD3. Western blot analysis with anti-FLAG antibody consistently showed one band corresponding to the FLAGtagged full-length protein (Figure 1c) . However, analysis of the same extract with anti-SMYD3 antibody detected two bands. These data suggested that the full-length protein was cleaved in the N-terminal region of SMYD3. Since western blot analysis of HEK293 cells expressing N-terminal deletion mutants (FLAG-SMYD3-DN44, -DN99 and -DN249) with anti-SMYD3 antibody showed a single band, the cleavage site of SMYD3 was predicted to localize between codons 1 and 45.
Determination of cleavage site of SMYD3 protein
In an attempt to determine the exact cleavage site of SMYD3, we purified the 42-kDa protein from polyvinylidene fluoride (PVDF) membrane transferred with immunoprecipitated FLAG-tagged SMYD3 protein (Figure 1b) , and determined its amino acid sequence. As a result, we identified a deleted form of SMYD3 protein lacking 34 N-terminal amino acids, which revealed a cleavage site between codon 34 (aspartic acid) and codon 35 (proline) (Figure 2a ). SMYD3 contains an amino acid sequence termed SET-N region between codons 5 and 27, which is conserved in SET domain proteins (Kouzarides, 2002; Lachner and Jenuwein, 2002; Marmorstein, 2003) . An alignment of amino acid sequences of SET-N region depicted the high similarity of the region between SMYD3 and other SET domain-containing methyltransferases (Figure 2b ), indicating the importance of this region.
Increased HMTase activity of the cleaved SMYD3 compared with the wild-type protein To investigate the methyltransferase activity of the cleaved SMYD3 protein, we expressed 3 Â FLAG-tagged wild-type, or a deleted form of SMYD3 (-DN34) exogenously in HEK293 cells, and immunoprecipitated these proteins (Figure 3a ). During the methylation process, S-adenosyl methionine (SAM) is catalysed to S-adenosyl homocysteine (SAH), whose accumulation is supposed to compete with SAM leading to the inhibition of methylation. We thus carried out a HMTase assay using wild-type and deleted SMYD3 proteins with or without S-adenosyl homocysteine hydrolase (SAHH) that hydrolyses SAH to homocysteine and adenosine. As we expected, addition of SAHH in the reaction mixture enhanced HMT activity ( Figure 3b ). This finding should be useful for in vitro screening of methyltransferase inhibitor(s). To our surprise, we found that the cleaved SMYD3 protein had significantly higher HMTase activity compared to the full-length protein ( Figure 3b ). Consistently, exogenous expression of cells with the cleaved form of SMYD3 revealed an increased di-and tri-methylation of H3-K4 in comparison with that of wild-type SMYD3 (Supplementary Figure 1A) . Immunocytochemical staining indicated nuclear and cytoplasmic localization of the cleaved protein in the cells, which is the same subcellular localization with the full-length protein (Supplementary Figure 1B) . These data suggested that the N-terminal SET-N region may have a suppressive role for the HMTase activity, and that cleavage of this region may be involved in the regulation of SMYD3 HMTase activity. It is of note The histone methyltransferase activity of SMYD3 F Pittella Silva et al that the N-terminal region is important for the interaction with HSP90a, because wild-type SMYD3 but not the cleaved protein was capable of binding with HSP90a ( Supplementary Figure 2A) .
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Glycine 15 and 17 in the SET-N region is important for the HMT activity To determine the importance of the conserved amino acid sequence in the SET-N region for the suppressed methyltransferase activity, we prepared additional plasmids expressing mutant N-terminal FLAG-tagged SMYD3 proteins. Since glycines 15, 17 and 27 of SMYD3 are highly conserved in the SET-N region (Figure 2b ), we prepared SMYD3-SetNm1, -SetNm2 and -SetNm3 that contained substitutions of G15A/ G17A, G15A or G27A, respectively (Figure 4a ). Western blot analysis of the lysates from HEK293 cells expressing these mutants showed that the substitutions did not affect the cleavage of SMYD3 protein (Figure 4b , upper panel). However, HMTase assay using immunoprecipitated SMYD3 protein revealed that SMYD3-SetNm1 containing substitutions of both G15A and G17A has significantly enhanced activity compared to the wild-type protein, which was comparable to the cleaved SMYD3 protein (Figure 4c ). On the other hand, SMYD3-SetNm2 and -SetNm3 containing G15A or G27A, respectively, had similar HMTase activity to wild-type protein. These data suggest that glycines 15 and 17 in the SET-N region may play an important role for the regulation of HMTase activity of SMYD3. Notably, we found that SetNm1, but not SetNm2 or SetNm3 lost its interaction with HSP90a (Supplementary Figure 2B) . Since SMYD3-DN34 and SetNm1 showed augmented HMTase activity, the N-terminal region may play a suppressive role for the HMTase activity. Considering that HSP90a increases HMTase activity of wild-type SMYD3, conformational change of the N-terminal region by HSP90a may be involved in the regulation. Substitution of glycine 15 or 27 alone may not be enough to alter the protein conformation into full active form.
Deletion of nine N-terminal amino acids is critical for the enhanced HMTase activity
The finding that the deletion or mutation of SMYD3 N-terminal region enhanced its enzymatic activity tempted us to hypothesize two possible mechanisms; the N-terminal region might associate with undetermined negative regulatory factor(s) for the enzyme activity, or the deletion or substitution might confer conformational change of the protein leading to enhanced enzyme activity. To determine whether additional negative regulatory factor(s) may play a role in the enzyme activity, we prepared wild-type and N-terminal deleted recombinant SMYD3 proteins, and investigated their HMTase activity in vitro. As shown in Figure 5 , all deletions mutants (SMYD3-DN9, -DN19, -DN29, -DN44, -DN74) exhibited four-to five-fold enhanced methyltransferase activity compared to the wild-type protein in the absence of HSP90a ( Figure 5) . Notably, H-radioactivity was measured by liquid scintillation counter.
The histone methyltransferase activity of SMYD3 F Pittella Silva et al SMYD3-DN9 failed to associate with HSP90a, suggesting that the nine amino acids in the N-terminal region are essential for the binding with HSP90a (data not shown). These data suggest that additional factors are not likely to play a role in the elevated activity of the deleted proteins, and that the conformational change of the SMYD3 protein by cleavage of its N-terminal region may be involved in the regulation of its methyltransferase activity.
Discussion
The regulation of a protein function depends on its expression level, as well as post-translational modifications including acetylation, phosphorylation, methylation, glycosylation, sumoylation and ubiquitination (Yang, 2005) . In addition to these modifications, the cleavage of proteins also plays a crucial role in the regulation. For example, a number of enzymes such as pepsin, insulin, caspases, PARP and MMPs are regulated by cleavage. These proteins are expressed as proenzymes or inactive forms of enzymes, and the cleavage in a specific region of their amino acid chain induces their enzyme activity. We uncovered in this report that the full-length SMYD3 protein is cleaved between codons 34 and 35 in the N-terminal region, and that the cleaved protein has higher methyltransferase activity compared to the full-length protein. This finding additionally suggests that an undetermined mechanism of the cleavage may be involved in the modulation of SMYD3 HMTase activity. A public peptidase database termed 'MEROPS' (Rawlings et al., 2006) predicted Caspase-3, -7 and -8 as candidate proteases for the cleavage of 'SDPL', the amino acid sequence between codons 33 and 36 in SMYD3. It have been reported that caspase-3 recognizes the exact sequence 'SDPL' in the microtubule-associated protein tau, and cuts the protein between 'D' and 'P' in neurodegenerative disorders (Fasulo et al., 2000) . Although further investigations are needed for the identification of the responsible protease, clarification of the regulatory mechanism of the cleavage will contribute to a profound understanding of methyltransferase activity. SMYD3 has a growth-promoting effect in NIH3T3 cells, and its suppression leads to the induction of apoptosis in colorectal cancer, hepatocellular carcinoma and breast cancer. Therefore, inhibitors of SMYD3 should be a rational strategy to treat these types of cancer. To confirm the transforming activity of the cleaved SMYD3, we carried out colony formation assay using the cleaved form or the full-length SMYD3 in NIH3T3 cells. Although both SMYD3-DN34 and full-length SMYD3 showed increased number of colonies compared with mock, the number of colonies was similar between the two forms (data not shown). This result may imply that the HMTase activity of full-length SMYD3 should be enough to induce the growth-promoting effect. It is tempting to hypothesize that HMTase activity of SMYD3 greater than a threshold may be needed to switch on the growth-promoting pathway, and that undetermined factor(s) may regulate the level of effect. Further investigation is necessary for the clarification of mechanism(s). Although inhibitors of SU(VAR)3-9, a histone H3-K9-specific HMTase have been identified (Greiner et al., 2005) , those of histone H3-K4-specific HMTases have not been reported so far. Since the cleaved form of SMYD3 has higher enzymatic The histone methyltransferase activity of SMYD3 F Pittella Silva et al activity compared to full-length protein, the cleaved form may be more useful for the discovery of inhibitors. In addition, we showed that the addition of SAHH in the in vitro methyltransferase assay enhances the activity through hydrolysis of SAH, a catalysed product of SAM (Fontecave et al., 2004) . These findings should contribute to the development of anti-cancer drug(s) targeting SMYD3. SET domain containing proteins have been grouped into several subfamilies according to the distribution of their conserved domains such as pre-SET domain, post-SET domain, post-SET AWS domain and N-terminal SET, C-Terminal Zn-finger domains (Jacobs et al., 2002; Zhang et al., 2002) . The SET domain consists of two non-contiguous region formed as SET-N and SET-C (Marmorstein, 2003) The SET-N region of SMYD3 contains three glycines that are highly conserved in several methyltransferases. The evidence that substitution of the conserved glycines (G15 and G17) diminished the interaction with HSP90a (Supplementary Figure 2B ) and enhanced its methyltransferase activity corroborated the importance of the conserved glycines in the SET-N region. Since cleavage of the N-terminal region also increased its methyltransferase activity, this region should have a suppressive role for the enzyme activity. In our earlier study, we showed that addition of HSP90a enhanced the methyltransferase activity of the full-length protein in vitro (Hamamoto et al., 2004) . These data are tempting us to speculate that the suppressive role in the N-terminal region may be regulated post-translationally through the cleavage or conformational change of the protein. This hypothesis needs to be investigated in future studies including crystal structure of SMYD3.
We have shown here that an N-terminal cleaved form of SMYD3 protein is expressed in cancer cells and that the cleaved protein has markedly higher HMTase activity than the full-length protein. These data implied that a post-translational regulatory system might play a role in the control of methyltransferase activity through a possible conformational change of the protein. In addition, we showed that the SET-N region of SMYD3 is important for the regulation of the methyltransferase activity. We also found that addition of SAHH increases the methyltransferase activity what could be valuable information for the screening of methyltransferase inhibitors. These findings will help for the better understanding of the regulatory mechanisms of SMYD3 activity, and may contribute to the identification of novel therapeutic strategies to inhibit the HMTase activity.
Materials and methods
Cell lines and tissue specimens
Human embryonic kidney 293 (HEK293), HEK293T and HEK293F cells were purchased from IWAKI. A human hepatoma cell line HepG2, and human colon cancer lines HCT116 and SW480 were obtained from the American Type Culture Collection. A human HCC cell line SNU423 was a gift from the Korea cell-line bank. T47D and MCF7 breast cancer cell lines were kindly provided from the cancer institute of the Japanese foundation for cancer research. All cell lines were grown in monolayers in appropriate media. Primary breast cancer tissues were obtained with informed consent from patients (Hamamoto et al., 2006) .
Preparation of plasmids
Preparation of C-terminal FLAG-tagged SMYD3 was described previously (Hamamoto et al., 2004) . We additionally prepared plasmids expressing N-terminal HA-tagged, or N-terminal 3 Â FLAG-tagged SMYD3 by cloning various PCR products containing either wild-type or deleted forms of SMYD3 cDNA into the appropriate site of pCMV-HA (Clontech, Palo Alto, CA, USA) or p3XFLAG-CMV10 The histone methyltransferase activity of SMYD3 F Pittella Silva et al (Sigma, St Louis, MO, USA) vector. Primers used for wildtype plasmids were 5 0 -AAGCTTGCGGCCGCGATGGAGC CGCTGAAGGTGGAAAAG-3 0 , and 5 0 -GGTACCTCTAGA TTAGGATGCTCTGATGTTGGCGTC-3 0 , and those used for mutants (FLAG-SMYD3-DN34, -DN44, -DN99 and -DN249) were 5 0 -GGGGTACCTTAGGATGCTCTGATGTTGGCGT C-3 0 and 5 0 -CGGAATTCACCCTTGGCGTACACGGTGTGC AAGG-3 0 , 5 0 -CGGAATTCTGGCGCGATGGAGCCGCTGA AGGTGGAAAAG-3 0 , 5 0 -CGGAATTCTGACTCCGTTCGAC TTCTTGGCAG-3 0 or 5 0 -CGGAATTCTCGGAAGCAGCTGA GGGACCAGTACTGC-3 0 , respectively. Mutant plasmids expressing substitution(s) at glycine 15, 17 or 27 were prepared using QuikChange II XL site-directed mutagenesis Kit according to the supplier's protocol (Stratagene, Cedar Creek, TX, USA).
Western blot analysis
A polyclonal antibody to SMYD3 was purified from sera of rabbits immunized with a recombinant His-tagged SMYD3 protein produced in Escherichia coli as described elsewhere. Proteins were separated by 10% SDS-polyacrylamide gel electrophoresis and immunoblotted with anti-SMYD3, anti-HA (Sigma), anti-FLAG (Sigma), anti-GST (BD-Pharmingen, San Diego, CA, USA) or anti-b-actin (Sigma) antibody. HRPconjugated anti-rabbit immunoglobulin G (IgG), anti-mouse IgG (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) or anti-goat IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody served as the secondary antibody for the ECL Detection System (Amersham).
Determination of cleavage site C-terminal-FLAG-tagged SMYD3 was expressed exogenously in 293F cells. SMYD3 protein was immunoprecipitated with anti-FLAG antibody from the cells, separated on duplicated SDS-polyacrylamide gel electrophoresis gels, and transferred to a nitrocellulose membrane and a sequence grade PVDF membrane. The nitrocellulose membrane was used for immunoblot analysis with anti-FLAG antibody to detect the two forms of SMYD3 protein. After staining of the PVDF membrane with CBB solution without acetic acid (0.025% CBB in 40% methanol), we excised the band corresponding to the short form of SMYD3 and subjected to amino acid sequence. The amino acid sequence of the protein was determined by Edman amino acid sequence method (Shimadzu Biotechnologies, Tokyo, Japan).
In vitro histone methyltransferase assay FLAG-tagged SMYD3 was purified from 293T cells expressing wild-type (p3XFLAG-CMV-SMYD3) or mutant SMYD3 (p3 Â FLAG-DN34, -DN44, -SetNm1, -SetNm2 and -SetNm3) by immunoprecipitation with anti-FLAG antibody. GST-fused SMYD3 proteins were purified from bacterial cells expressing wild-type (GST-SMYD3-wt) or mutant SMYD3 constructs (GST-SMYD3-DN9, -DN19, -DN29, -DN44, -DN74). In vitro HMTase assay was performed as described elsewhere (Hamamoto et al., 2004) .
